| Adenocarcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 326show all (up to 200) |
|---|
| → investigated in trials for | Pembrolizumabmonoclonal antibody 377 trials (172 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 377 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall_molecule 272 trials (107 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 272 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 264 trials (103 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 264 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 263 trials (92 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 263 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal_antibody 244 trials (100 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 244 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 229 trials (14 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 229 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 220 trials (94 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 220 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 181 trials (75 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 181 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall_molecule 177 trials (62 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 177 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 172 trials (77 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 172 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall_molecule 172 trials (65 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 172 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 149 trials (62 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 149 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 149 trials (47 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 149 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 148 trials (58 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 148 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 131 trials (9 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 131 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 124 trials (64 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 124 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 115 trials (46 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 115 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 106 trials (61 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 106 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 104 trials (52 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 104 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 103 trials (51 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 103 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall_molecule 100 trials (33 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 100 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 97 trials (33 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 97 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall_molecule 90 trials (37 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 90 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 80 trials (10 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 80 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 67 trials (33 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 67 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 66 trials (21 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 66 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 61 trials (35 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 61 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal_antibody 58 trials (30 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 56 trials (4 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 56 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 55 trials (18 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 55 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 54 trials (22 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 54 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 53 trials (32 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 53 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 48 trials (20 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal_antibody 48 trials (23 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 37 trials (13 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 37 trials (11 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 37 trials (12 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 36 trials (14 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 36 trials (27 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 34 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 33 trials (11 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 32 trials (11 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 32 trials (16 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 32 trials (8 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall_molecule 32 trials (9 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 31 trials (4 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leuprolideother 31 trials (14 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 30 trials (12 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Goserelinother 30 trials (15 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 29 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 29 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Letrozolesmall molecule 28 trials (17 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bicalutamidesmall molecule 27 trials (10 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 27 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 26 trials (6 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belzutifansmall molecule 25 trials (20 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 24 trials (12 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 24 trials (3 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 23 trials (10 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abiraterone Acetatesmall molecule 21 trials (11 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 21 trials (9 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tamoxifensmall molecule 21 trials (10 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX Regimen 18 trials (9 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 18 trials (5 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tivozanibsmall molecule 18 trials (4 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Apalutamidesmall molecule 17 trials (11 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 17 trials (10 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 17 trials (3 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 14 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Degarelixother 14 trials (9 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 14 trials (4 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 14 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 14 trials (3 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 14 trials (3 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 14 trials (4 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 14 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anastrozolesmall molecule 13 trials (8 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 13 trials (10 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 13 trials (5 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pertuzumabmonoclonal antibody 13 trials (4 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 13 trials (6 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 12 trials (9 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 12 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Exemestanesmall molecule 12 trials (8 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 12 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 12 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 12 trials (3 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 12 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 12 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 10 trials (7 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abirateronesmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 9 trials (6 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Disitamab Vedotinadc 9 trials (8 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumab/Nivolumab Regimen 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall_molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Neratinibsmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegargiminaseother 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 9 trials (7 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alpelisibsmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 8 trials (6 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Flutamidesmall molecule 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD1 Monoclonal Antibody 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Datopotamab Deruxtecanadc 7 trials (7 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX-4 Regimen 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hormone Therapy 7 trials (6 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipatasertibsmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Relugolixsmall molecule 7 trials (7 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Retifanlimabmonoclonal antibody 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tegafursmall_molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabazitaxelsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFIRI Regimen 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fruquintinibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganetespibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunotherapy 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sonidegibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talimogene Laherparepvecgene therapy 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Triptorelinother 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vandetanibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capmatinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Futibatinibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Icotinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lutetium (177lu) Vipivotide Tetraxetanother 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mirvetuximab Soravtansineadc 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Savolitinibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tucatinibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanidatamabmonoclonal antibody 5 trials (5 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin/Paclitaxel Regimen 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Darolutamidesmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dordavipronesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dovitinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elimusertibsmall molecule 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enfortumab Vedotinadc 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganitumabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Histrelinother 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hyperthermic Intraperitoneal Chemotherapy 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immune Checkpoint Inhibitor 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Levoleucovorinsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selpercatinibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vistusertibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afimoxifenesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aromatase Inhibitor 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avutometinib And Defactinib 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Berzosertibsmall molecule 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ceritinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dinaciclibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elacestrantsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Entrectinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Estramustinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Firmonertinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Guadecitabinesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idarubicinsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imiquimodsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immunomodulatory Oligonucleotide 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linifanibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nilutamidesmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pasireotideother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Adenocarcinoma | 3 | Observed | clinicaltrials | graph → |